In addition, it showed association with poor prognosis and remained as an independent prognostic factor after adjusting with selected clinicopathological parameters (tumor subsites and tumor differentiation) but the prognostic value of MMP13 was attenuated after controlling with lymph node status and tumor staging. This evidence concerns the gene MMP13 and neoplasm.